---
layout: post
title: "Defining Durations of Use for Approved Medically Important Antimicrobial Drugs Fed to Food-Producing Animals; Draft Guidance for Industry; Extension of the Comment Period"
date: 2026-02-05 18:57:41 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-25962
original_published: 2023-11-24 00:00:00 +0000
significance: 8.00
---

# Defining Durations of Use for Approved Medically Important Antimicrobial Drugs Fed to Food-Producing Animals; Draft Guidance for Industry; Extension of the Comment Period

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** November 24, 2023 00:00 UTC
**Document Number:** 2023-25962

## Summary

The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice of availability that published in the Federal Register of September 26, 2023. In that notice, FDA requested comments on the draft guidance for industry (GFI) #273 entitled "Defining Durations of Use for Approved Medically Important Antimicrobial Drugs Fed to Food-Producing Animals." The Agency is taking this action in response to requests for an extension to allow interested persons additional time to develop and submit comments.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/11/24/2023-25962/defining-durations-of-use-for-approved-medically-important-antimicrobial-drugs-fed-to-food-producing)
- API: https://www.federalregister.gov/api/v1/documents/2023-25962

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
